Real-World Applicability of Anti-VEGF Trial Criteria for Diabetic Macular Edema

Macular DiseasesRetinal Diseases

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Sci Rep

Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST

doi: 10.1038/s41598-025-20300-6

Macular Diseases

Assessment of real-life visual outcomes and treatment efficacy of diabetic macular edema in patients with type 2 diabetes

BMC Ophthalmol

Konttinen A, Wirkkala J, Kubin AM, Ohtonen P, Hautala N

doi: 10.1186/s12886-026-05083-2

Macular Diseases

Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema

J Clin Med

Liu DY, Wu SL, Hsia NY, Tien PT, Lin CJ, Wang I, Lai CT, Lin JM, Huang YT, Wu BQ, Lin WN, Ku WN, Meng PP, Chen HS, Tsai YY

doi: 10.3390/jcm15166356

Macular Diseases

Real-World Outcomes in Neovascular AMD with Visit Gaps under Anti-VEGF Therapy: Data from the FRB! Registry

Ophthalmol Retina

Goncalves L, Hashimoto Y, Barthelmes D, Barry R, Pollreisz A, Wolff B, Toole LO, Ponsioen TL, Morros HB, Creuzot-Garcher C, Gillies M, Gabrielle PH

doi: 10.1016/j.oret.2026.04.007

Retinal DiseasesFurther Publications

Real-world retinal vasculitis events reported with FDA-approved intravitreal anti-VEGF and complement inhibitor agents: an analysis of FAERS data

Retina

Chhablani J, Nayaka A, Sadeghi E, B G

doi: 10.1097/IAE.0000000000004980

Macular Diseases

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

BMJ Open Ophthalmol

Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K

doi: 10.1136/bmjophth-2025-002467

Glaucoma and Ocular PressureUveitis

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

Retina

Hamdan SA, Zafar S, Nassur JA, Yonekawa Y, Kuriyan AE, Dunn JP, Cohen MN, Hsu J, Regillo CD, Garg SJ, Xu D, Klufas M, Deaner JD

doi: 10.1097/IAE.0000000000004677

Macular DiseasesRetinal Diseases

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report

Ophthalmol Ther

Heck K, Hatz K, Cattaneo M, Pfister I, Magnin S, Ruscitti L, Stasik I, Tillmann A, Shamshiev M, Fang J, Weinberger A, Zweifel SA, Garweg JG, Eandi CM, Grimaldi G, Munk MR, Somfai GM, Ambresin A, Feltgen N

doi: 10.1007/s40123-026-01442-w

Macular Diseases

Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial

Ophthalmology

Do DV, Wykoff CC, Sivaprasad S, Brown DM, Boyer DS, Sakamoto T, Win P, Joshi S, Salehi-Had H, Seres A, Berliner AJ, Leal S, Vitti R, Chu KW, Reed K, Cheng Y, Bhore R, Bai Z, Schmidt-Ott U, Schmelter T, Schulze A, Hasanbasic Z, Morgan-Warren PJ, Zhang X, Hirshberg B, Yancopoulos GD, PHOTON investigators

doi: 10.1016/j.ophtha.2025.10.028

Related content

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Assessment of real-life visual outcomes and treatment efficacy of diabetic macular edema in patients with type 2 diabetes

Beyond Central Subfield Thickness: Early Multi-Slice Optical Coherence Tomography Structural Response After Faricimab Injection in Real-World Diabetic Macular Edema

Real-World Outcomes in Neovascular AMD with Visit Gaps under Anti-VEGF Therapy: Data from the FRB! Registry

Real-world retinal vasculitis events reported with FDA-approved intravitreal anti-VEGF and complement inhibitor agents: an analysis of FAERS data

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report

Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial